Abbott S.A./NV

Novirio Looks To Go Public, Files For Estimated $115M IPO.
BIOWORLD Today; 11/4/2009; 1085 words; ...than $69 million from U.S., European and Asian investors...trial. The company also has NV-02A and NV-06, two preclinical HBV...chief operating officer of Abbott Laboratories, of Abbot Park, Ill. Before Abbott, Hodgson was an associate...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1947 words; ...in September. RSD1235's mechanism of action involves...Emeryville, Calif., granted Abbott Laboratories, of Abbot...exclusive license in the U.S. (including Puerto Rico...manufacture and market DepoMed's Metformin GR. The agreement...Galapagos Genomics NV, of Mechelen, Belgium...

Dyax Raising $38.5 Million To Fund Its DX-88 Trials.
BIOWORLD Today; 11/3/2009; 1125 words; ...the decision. Dyax's shares (NASDAQ:DYAX...requirements. Dyax's two target indications...Behring, Pharming Group NV and Jerini AG in partnership with Abbott Laboratories. In the...house using the company's phage display technology...

NewCo News: Tacere Tries A New Strategy By Fighting HCV With RNAi.
BIOWORLD Today; 11/3/2009; 1093 words; ...033 along with Benitec's broad patent on expressed...Thus far, Tacere's funding has come from a...545 million ex-U.S. rights deal between Vertex and Janssen Pharmaceutica NV, a potential $530 million...Pharmaceuticals Inc. and Abbott Laboratories Inc. Novartis...

Pharma's Shopping Continues, With Focus On Antibody Firms.
BIOWORLD Today; 11/3/2009; 1285 words; ...to buyout talks. As an example of pharma's dire need to compete in the antibody arena, note that only Humira, majority owned by Abbott Laboratories, of Abbott Park, Ill., cracks RBC's list of antibody drugs with heavy-hitter...